CR20130199A - METHOD OF IDENTIFICATION OF RISK FACTORS OF THE DISEASE - Google Patents

METHOD OF IDENTIFICATION OF RISK FACTORS OF THE DISEASE

Info

Publication number
CR20130199A
CR20130199A CR20130199A CR20130199A CR20130199A CR 20130199 A CR20130199 A CR 20130199A CR 20130199 A CR20130199 A CR 20130199A CR 20130199 A CR20130199 A CR 20130199A CR 20130199 A CR20130199 A CR 20130199A
Authority
CR
Costa Rica
Prior art keywords
disease
identification
risk factors
genetic
variante
Prior art date
Application number
CR20130199A
Other languages
Spanish (es)
Inventor
Allen D Roses
Original Assignee
Zinfandel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zinfandel Pharmaceuticals Inc filed Critical Zinfandel Pharmaceuticals Inc
Priority to CR20130199A priority Critical patent/CR20130199A/en
Publication of CR20130199A publication Critical patent/CR20130199A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

AQUI SE PROPORCIONA UN MÉTODO PARA LA IDENTIFICACIÓN DE UNA VARIANTE QUE ESTÁ ASOCIADA CON EL DESARROLLO DE UN PADECIMIENTO DE INTERÉS (POR EJEMPLO, LA ENFERMEDAD DE ALZHEIMER), Y LAS VARIANTES GENÉTICAS IDENTIFICADAS DE ESTA MANERA. TAMBIÉN SE PROPORCIONAN MÉTODOS DE TRATAMIENTO CON UN INGREDIENTE ACTIVO (POR EJEMPLO, CON UN AGENTE ACTIVO PARTICULAR Y / O EN UNA ETAPA MÁS TEMPARANA), AL MOMENTO DE DETECTAR UNA VARIANTE GENÉTICA AQUÍ DESCRITA. EN ALGUNAS MODALIDADES, LA VARIANTE GENÉTICA ES UN POLIMORFISMO DE ELIMINACIÓN / INSERCIÓN (DIP) DEL GEN TOMM40.-HERE IS PROVIDED A METHOD FOR THE IDENTIFICATION OF A VARIANTE THAT IS ASSOCIATED WITH THE DEVELOPMENT OF AN INTEREST OF INTEREST (FOR EXAMPLE, THE DISEASE OF ALZHEIMER), AND THE GENETIC VARIANTS IDENTIFIED IN THIS WAY. METHODS OF TREATMENT ARE ALSO PROVIDED WITH AN ACTIVE INGREDIENT (FOR EXAMPLE, WITH A PARTICULAR ACTIVE AGENT AND / OR IN A MORE TEMPARIAN STAGE), AT THE TIME OF DETECTING A GENETIC VARIANT DESCRIBED HEREIN. IN SOME MODES, THE GENETIC VARIANTE IS AN ELIMINATION / INSERTION POLYMORPHISM (DIP) OF THE TOMM40 GEN.-

CR20130199A 2013-05-02 2013-05-02 METHOD OF IDENTIFICATION OF RISK FACTORS OF THE DISEASE CR20130199A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR20130199A CR20130199A (en) 2013-05-02 2013-05-02 METHOD OF IDENTIFICATION OF RISK FACTORS OF THE DISEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR20130199A CR20130199A (en) 2013-05-02 2013-05-02 METHOD OF IDENTIFICATION OF RISK FACTORS OF THE DISEASE

Publications (1)

Publication Number Publication Date
CR20130199A true CR20130199A (en) 2013-10-23

Family

ID=51359533

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20130199A CR20130199A (en) 2013-05-02 2013-05-02 METHOD OF IDENTIFICATION OF RISK FACTORS OF THE DISEASE

Country Status (1)

Country Link
CR (1) CR20130199A (en)

Similar Documents

Publication Publication Date Title
HUS2200011I1 (en) Compositions and methods for inhibiting the expression of the HAO1 (hydroxy acid oxidase-1 (glycolate oxidase)) gene
CL2015002127A1 (en) Systems and methods for clinical decision support.
MX372723B (en) METHODS FOR LABELING A DEUTERATED OR NON-DEUTERATED MOLECULE AND PHARMACEUTICAL FORMULATIONS FOR TREATMENT.
MX2016011538A (en) Antisense nucleic acid.
MX2018002955A (en) Antisense nucleic acid.
EP3484994A4 (en) CRISPR-CAS-SYSTEM FOR AN ALGENE CELL
CO2017013065A2 (en) Diaciglycerol acyltransferase 2 modulators (dgat2)
CL2018000596A1 (en) New bicyclic compounds as atx inhibitors
PE20180260A1 (en) METHODS AND KITS TO TREAT DEPRESSION
MX392552B (en) METHODS FOR ISOLATING MICROVESICLES.
BR112018001853A2 (en) methods for treating a disorder and for improving the treatment of a disorder
MX2017005820A (en) MICROAGUJAS ARRANGEMENTS FOR APPLICATIONS IN CANCER THERAPIES.
MX2016004865A (en) METHOD AND DEVICE FOR ANALYZING SOCIAL RELATIONSHIP.
BR112018069303A2 (en) method for treating an infection
MX2015012176A (en) Methods of using zscan4 for rejuvenating human cells.
BR112017009554A2 (en) inspection device for use in a fluid container and inspection device for use in a fluid
MX2016013877A (en) Compositions and methods for enhancing and/or predicting dna amplification.
EP3498836A4 (en) MANUFACTURING PROCESS FOR L-AMINO ACID
CL2014002975A1 (en) In vitro method for the diagnosis and surveillance of cancer, which comprises determining the ratio between treg cells and another group of t cells, selected from th17, th1 and / or th2.
CL2016002754A1 (en) Treatment device and treatment procedure for pickling and phosphating metal parts
MX2017007000A (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same.
MX2016012248A (en) Compositions for the treatment of autodigestion.
BR112017013256A2 (en) method of analysis, disk-shaped sample holder and application of a sample holder
BR112016028909A2 (en) method and device for tissue closure
UY34189A (en) FUNGICIDE BLENDS THAT INCLUDE ISOXAZOL AND OTHER ACTIVE INGREDIENT.